{
    "code": "02024410",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024410",
    "time": "2020-02-25 13:21:51",
    "許可證字號": "衛署藥輸字第024410號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/07\/26",
    "註銷理由": "屆期未申請展延",
    "有效日期": "105\/03\/14",
    "發證日期": "95\/03\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202441005",
    "中文品名": "得舒緩膜衣錠100毫克",
    "英文品名": "Tarceva Film-Coated tablets 100mg",
    "適應症": "適用於具有EGFR-TK突變之局部侵犯性或轉移性之非小細胞肺癌(NSCLC)病患之第一線治療。\r\n適用於先前已接受過化學治療後，但仍局部惡化或轉移之肺腺癌病患之第二線用藥。\r\n適用於已接受4個週期含platinum-based第一線化學療法且尚未惡化的局部晚期或轉移性肺腺癌的維持療法。",
    "劑型": "116膜衣錠",
    "包裝": "3-1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 1Q不得輸入 58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥",
        "申請商名稱": "1901701100  羅氏大藥廠股份有限公司",
        "申請商地址": "台北市松山區民生東路三段１３４號９樓",
        "主製造廠": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013001000",
            "成分名稱": "ERLOTINIB HYDROCHLORIDE",
            "含量描述": "",
            "含量": "109.2900000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020244100001-2014-04-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024410&Seq=007&Type=9"
        },
        {
            "title": "020244100002___20101102.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024410&Seq=002&Type=8"
        }
    ]
}